Kiniksa Pharmaceuticals International, plc (KNSA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.06B |
| Enterprise Value | 2.9B |
| P/E Ratio | 73.86 |
| PEG Ratio | 0.04 |
| Price/Sales Ratio | 7.16 |
| Price/Book Ratio | 9.37 |
| Enterprise/Revenue | 6.96 |
| Enterprise/EBITDA | 52.24 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.1 |
| Operating Margin | 0.12 |
AD
Management Effectiveness
| Return On Assets | 0.09 |
| Return On Equity | 0.14 |
Income Statement
| Revenue | 677.56M |
| Revenue/Share | 10.84 |
| Gross Profit | 370.15M |
| EBITDA | 90.42M |
| Net Income | 59.01M |
| Diluted EPS | 0.75 |
Balance Sheet
| Total Cash | 525.93M |
| Total Cash/Share | 6.78 |
| Total Debt | 8.9M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 3.9 |
| Book Value Per Share | 8.43 |
Price History
| 52-Week Change | 134.16 |
| 52-Week High | 82.94 |
| 52-Week Low | 32.89 |
| Moving Average 50 Days | 67.03 |
| Moving Average 200 Days | 50.91 |
Statistics
| Average Volume | 754,974 |
| Shares Outstanding | 76.21M |
| % Held by Institutions | 61.45 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
